Clinical trials

This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insulin independency over 52 weeks with teplizumab…

Investigator

Michael J Haller

Ages

1 Year - 25 Years

Sexes

All

This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell therapy manufactured from a participant's own blood…

Investigator

Brittany S Bruggeman

Ages

18 Years - 55 Years

Sexes

All

This is a Phase 2b, investigator* and participant-blinded, placebo-controlled, parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D).

Investigator

Laura Jacobsen

Ages

5 Years - 40 Years

Sexes

All